Kiora appoints Walters-Hoffert to board, promotes Tosca to CFO, regains Nasdaq compliance

KIORA PHARMACEUTICALS INC

Lisa Walters-Hoffert appointed independent director and audit committee chair; Kenneth Gayron resigned.
Melissa Tosca promoted from EVP of Finance to CFO; salary raised to $337,000, bonus target to 40%.
CEO Brian Strem's salary increased to $569,000 (55% bonus); Chief Development Officer Daniels to $443,000 (40%).
New non-employee director compensation: initial 1,778 stock option grant, cash retainers up to $70,000 annually.
Regained compliance with Nasdaq minimum bid price rule (Nasdaq Listing Rule 5550(a)(2)) as of June 28, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.